Close Menu

Get Personal

With its purchase of SeqWright for an undisclosed sum, GE is investing more in personalized medicine, The Wall Street Journal's Health Blog says. SeqWright is a contract genomic research organization that offers sequencing services among others, and GE says the company will supplement its 2009 purchase of Clarient, a cancer diagnostics company, for $580 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.